Skip to content
10-Q

Quarterly Report

GENEREX BIOTECHNOLOGY CORP

0001607062-20-000353

← back to feed
Filed
Dec 21, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Dec 21, 2020 109.98M sh
Shares Diluted Q1 2020 · Oct 31, 2020 96.86M sh
Shares Diluted restated Q1 2020 · Oct 31, 2019 69.8M sh
Capex Q1 2020 · Oct 31, 2020 $0
Capex Q1 2020 · Oct 31, 2019 $4.45K
Operating Cash Flow Q1 2020 · Oct 31, 2020 −$1.34M
Operating Cash Flow Q1 2020 · Oct 31, 2019 −$1.84M
Short Term Debt Q1 2020 · Oct 31, 2020 $9.96M
Short Term Debt Q1 2020 · Jul 31, 2020 $10.67M
Cash And Equivalents Q1 2020 · Oct 31, 2020 $833.57K
Cash And Equivalents Q1 2020 · Jul 31, 2020 $15.45K
Cash And Equivalents Q1 2020 · Oct 31, 2019 $540.25K
Cash And Equivalents Q1 2020 · Jul 31, 2019 $298.49K
Stockholders Equity Q1 2020 · Oct 31, 2020 −$36.11M
Stockholders Equity Q1 2020 · Jul 31, 2020 −$11.96M
Stockholders Equity Q1 2020 · Oct 31, 2019 $4.87M
Stockholders Equity Q1 2020 · Jul 31, 2019 $7.67M
Current Liabilities Q1 2020 · Oct 31, 2020 $52.44M
Current Liabilities Q1 2020 · Jul 31, 2020 $41.37M
Total Liabilities Q1 2020 · Oct 31, 2020 $77.92M
Total Liabilities Q1 2020 · Jul 31, 2020 $53.27M
Current Assets Q1 2020 · Oct 31, 2020 $2.04M
Current Assets Q1 2020 · Jul 31, 2020 $1.25M
Total Assets Q1 2020 · Oct 31, 2020 $45.89M
Total Assets Q1 2020 · Jul 31, 2020 $45.38M
Eps Diluted Q1 2020 · Oct 31, 2020 −$0.11
Eps Diluted restated Q1 2020 · Oct 31, 2019 −$0.13
Eps Basic Q1 2020 · Oct 31, 2020 −$0.11
Eps Basic restated Q1 2020 · Oct 31, 2019 −$0.13
Sga Expense Q1 2020 · Oct 31, 2020 $13.01M
Sga Expense Q1 2020 · Oct 31, 2019 $4.79M
Rd Expense Q1 2020 · Oct 31, 2020 $1.17M
Rd Expense Q1 2020 · Oct 31, 2019 $338.73K
Net Income Q1 2020 · Oct 31, 2020 −$10.99M
Net Income Q1 2020 · Oct 31, 2019 −$9.31M
Operating Income Q1 2020 · Oct 31, 2020 −$14.11M
Operating Income Q1 2020 · Oct 31, 2019 −$4.55M
Gross Profit Q1 2020 · Oct 31, 2020 $65.1K
Gross Profit Q1 2020 · Oct 31, 2019 $588.04K
Cost Of Revenue Q1 2020 · Oct 31, 2020 $23.33K
Cost Of Revenue Q1 2020 · Oct 31, 2019 $133.62K
Revenue Q1 2020 · Oct 31, 2020 $88.44K
Revenue Q1 2020 · Oct 31, 2019 $721.66K